Osteopathic Manipulation Makes a Neuropsychological Difference
BOD
Examining Osteopathic Manipulation on Making a Neuropsychological Brain of Difference in Adults With Pain: A BOD Study Protocol and Rationale for a New Approach
1 other identifier
interventional
100
1 country
1
Brief Summary
Patients with pain commonly experience cognitive impairment. While symptoms of pain are effectively treated with osteopathic manipulative treatment (OMT), the cognitive piece is vastly ignored. Pain-induced cognitive dysfunction can be severe and is particularly apparent in working memory and attention. There is good reason to also expect cognitive responsiveness to OMT. Previous research has already reported related psychiatric outcomes, including relief from stress, self-perception and anxiety, suggesting that OMT may produce more global effects on cortical processing than currently thought.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 6, 2017
CompletedFirst Posted
Study publicly available on registry
August 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
September 30, 2025
September 1, 2025
9.7 years
April 6, 2017
September 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
neuropsychology change
standardized assessment battery
baseline, week 8, week 12
pain scale change
1-10
baseline, week 8, week 12
inflammatory markers change
cortisol
baseline, week 8, week 12
inflammatory marker
TNF Alpha
baseline, week 8, week 12
Inflammatory marker
IL 6
baseline, week 8, week 12
Study Arms (1)
Osteopathic group
EXPERIMENTALTreatment will be compromised of 8 weeks of standard care plus OMT. Each physician will maintain the same patient at recurring sessions. Osteopathic treatment is performed for 30 minutes and the techniques applied are highly individualized to the patient needs (i.e., techniques are selected based on structure/function, and techniques change over time based on treatment response). In an effort to standardize treatment, we will limit the study protocol to the following designated techniques: facilitated positional release treatment, high velocity low amplitude treatment, articulatory treatment, strain-counterstrain, muscle energy treatment, myofascial release treatment, soft tissue treatment.
Interventions
Osteopathic manipulative treatment (OMT) is defined as the therapeutic application of manually guided forces by an osteopathic physician to improve physiologic function and/or support homeostasis that has been altered by somatic dysfunction. Somatic (body framework) dysfunction or altered function of related components is observed in the skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic, and neural elements. Techniques can use a direct method where the restrictive barrier is engaged and a final activating force is applied to correct the somatic dysfunction, or an indirect method where the restrictive barrier is disengaged and the dysfunctional body part is moved away from the restrictive barrier until tissue tension is equal in one or all planes and directions
This group will refrain from getting OMT while in the study.
Eligibility Criteria
You may qualify if:
- years of age or older;
- seeking treatment for acute or chronic pain (neck, thoracic, shoulder, back)
- gives a positive response to the item, "Have you had thinking problems because of your pain?";
- agree to forego extra-trial manipulation (e.g., massage, chiropractic, physical therapy);
- Score \> 23 on the Telephone Interview for Cognitive Status;
- written informed consent.
You may not qualify if:
- recent (\< 2 month) or planned surgery within the duration of the study;
- use of medication that could interfere with cytokine measurements;
- recent (\< 2 month) changes to psychotropic medication within the duration of the study;
- history of manipulation within the past six months.
- diagnosed neurocognitive disorders;
- contraindication to receiving OMT.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Midwestern Multispecialty Clinic
Downers Grove, Illinois, 60515, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
mireille rizkalla, phd
Midwestern University
- STUDY DIRECTOR
Katrina Ivkovic
Midwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 6, 2017
First Posted
August 15, 2019
Study Start
January 1, 2017
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
September 30, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share